通过多特征和多omics集成,对眼候选药物点的遗传优先考虑
Jianqi Chen1, Yangjiani Li1, Yingting Zhu1
1State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Sun Yat-Sen University, Guangzhou, 510060, Guangdong Province, China.
Eye and vision (London, England)
|July 9, 2025
概括
这项研究确定了包括CPXM1和FLT4在内的新型可药物基因,作为青光眼的潜在治疗点,为治疗这种致盲的疾病提供了新的途径.
科学领域:
- 遗传学和眼科 医学
- 药物基因组学 药物基因组学
- 药物发现 药物发现 药物发现
背景情况:
- 玻璃眼是导致不可逆转失明的主要原因.
- 目前的玻璃眼治疗有局限性,突出了需要新的治疗策略.
- 识别新的药物点对于有效的绿眼病管理至关重要.
研究的目的:
- 通过综合的多特征和多omic分析来确定青光眼的潜在药物点.
- 探索基因与绿眼病相关的基因机制.
- 调查候选治疗点的潜在不良影响.
主要方法:
- 利用了蛋白质组和转录组门德尔随机化 (MR) 和协同分析.
- 来源:从定量特征位置研究中获得的可用药物基因表达和蛋白质丰度数据.
- 从大规模的多特征分析中获得的综合遗传关联数据与玻璃眼.
主要成果:
- 确定了CPXM1,FLT4,INSR,CPZ和PXDN作为潜在的可药物基因.
- CPXM1,FLT4,INSR和CPZ显示了基因预测的关联与降低眼风险.
- PXDN与增加的玻璃眼风险有关; CPXM1和FLT4的关联被证实在整个转录组和通过局部化.
结论:
- 这项研究提供了对玻璃眼病理生理学的新见解.
- 已识别的基因,如CPXM1和FLT4,代表了对眼的有前途的药物标.
- 这些发现支持药物开发的创新,用于治疗青光眼.
相关概念视频
01:25Glaucoma: Overview
777
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
777
02:02Genomics
37.5K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
37.5K
01:27Open Angle Glaucoma: Treatment
583
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
583